Sanofi
SNW.XETRA
| Exchange: | XETRA |
| Currency | Euro |
| ISIN: | FR0000120578 |
| LEI: | 549300E9PC51EN656011 |
| Primary Ticker: | SAN.PA |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Drug Manufacturers - General |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Pharmaceuticals |
| Gic Sub Industry: | Pharmaceuticals |
| Description: | Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize Ig M antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France. |
| Address: | 46, avenue de la Grande Armée,, Paris, France, 75017 |
| Website: | https://www.sanofi.com |
| Full Time Employees: | 86088 |
| Updated On: | 2024-11-05 |
Highlights
| Market Capitalization: | 123728183296 |
| Market Capitalization Mln: | 123728.18 |
| EBITDA: | 12502500352 |
| PE Ratio: | 27.22 |
| PEG Ratio: | 0.79 |
| Wall Street Target Price: | 109.27 |
| Book Value: | 58.10 |
| Dividend Yield: | 0.03 |
| Earnings Share: | 3.59 |
| EPS Estimate Current Year: | 6.33 |
| EPS Estimate Next Year: | 7.06 |
| EPS Estimate Current Quarter: | 1.96 |
| Most Recent Quarter: | 2024-09-30 |
| Profit Margin: | 0.09 |
| Operating Margin TTM: | 0.28 |
| Return On Assets TTM: | 0.04 |
| Return On Equity TTM: | 0.05 |
| Revenue TTM: | 48445001728 |
| Revenue Per Share TTM: | 38.71 |
| Quarterly Revenue Growth YOY: | 0.11 |
| Gross Profit TTM: | 31697000000 |
| Diluted Eps TTM: | 3.59 |
| Quarterly Earnings Growth YOY: | 0.11 |
Valuation
| Trailing PE: | 27.22 |
| Forward PE: | 11.13 |
| Price Sales TTM: | 2.55 |
| Price Book MRQ: | 1.66 |
| Enterprise Value: | 140684417360 |
| Enterprise Value Revenue: | 2.87 |
| Enterprise Value Ebitda: | 15.53 |
Shares
| Shares Outstanding: | 1253580032 |
| Shares Float: | 1100558536 |
| Percent Insiders: | 11.88 |
| Percent Institutions: | 46.14 |
Technicals
| Beta: | 0.42 |
| 52 Week High: | 106.08 |
| 52 Week Low: | 80.12 |
| 50 Day MA: | 101.78 |
| 200 Day MA: | 93.40 |
Splits & Dividends
| Forward Annual Dividend Rate: | 3.76 |
| Forward Annual Dividend Yield: | 0.03 |
| Payout Ratio: | 1.31 |
| Ex Dividend Date: | 2024-05-13 |
Earnings
| Report Date: | 2025-10-24 |
| Date: | 2025-09-30 |
| Before After Market: | After Market |
| Currency: | EUR |
| Report Date: | 2025-07-23 |
| Date: | 2025-06-30 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Report Date: | 2025-04-24 |
| Date: | 2025-03-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Report Date: | 2024-10-25 |
| Date: | 2024-09-30 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | 2.86 |
| Eps Estimate: | 2.48 |
| Eps Difference: | 0.38 |
| Surprise Percent: | 15.32 |
| Report Date: | 2023-10-27 |
| Date: | 2023-09-30 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | 2.55 |
| Eps Estimate: | 2.61 |
| Eps Difference: | -0.06 |
| Surprise Percent: | -2.29 |
| Report Date: | 2023-07-28 |
| Date: | 2023-06-30 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | 1.74 |
| Eps Estimate: | 1.63 |
| Eps Difference: | 0.11 |
| Surprise Percent: | 6.74 |
| Report Date: | 2023-04-27 |
| Date: | 2023-03-31 |
| Before After Market: | Before Market |
| Currency: | EUR |
| Eps Actual: | 2.16 |
| Eps Estimate: | 2.01 |
| Eps Difference: | 0.15 |
| Surprise Percent: | 7.46 |
| Report Date: | 2021-06-30 |
| Date: | 2021-06-30 |
| Currency: | EUR |
| Eps Actual: | 1.38 |
| Eps Estimate: | 1.32 |
| Eps Difference: | 0.06 |
| Surprise Percent: | 4.54 |
| Report Date: | 2018-09-30 |
| Date: | 2018-09-30 |
| Currency: | EUR |
| Eps Actual: | 1.84 |
| Eps Estimate: | 1.73 |
| Eps Difference: | 0.11 |
| Surprise Percent: | 6.35 |
| Report Date: | 2018-06-30 |
| Date: | 2018-06-30 |
| Currency: | EUR |
| Eps Actual: | 1.25 |
| Eps Estimate: | 1.23 |
| Eps Difference: | 0.02 |
| Surprise Percent: | 1.62 |
| Report Date: | 2018-03-31 |
| Date: | 2018-03-31 |
| Currency: | EUR |
| Eps Actual: | 1.28 |
| Eps Estimate: | 1.14 |
| Eps Difference: | 0.14 |
| Surprise Percent: | 12.28 |
| Report Date: | 2017-12-31 |
| Date: | 2017-12-31 |
| Currency: | EUR |
| Eps Actual: | 1.06 |
| Eps Estimate: | 1.15 |
| Eps Difference: | -0.09 |
| Surprise Percent: | -7.82 |
| Report Date: | 2017-09-30 |
| Date: | 2017-09-30 |
| Currency: | EUR |
| Eps Actual: | 1.71 |
| Eps Estimate: | 1.72 |
| Eps Difference: | -0.01 |
| Surprise Percent: | -0.58 |
| Report Date: | 2017-06-30 |
| Date: | 2017-06-30 |
| Currency: | EUR |
| Eps Actual: | 1.35 |
| Eps Estimate: | 1.29 |
| Eps Difference: | 0.06 |
| Surprise Percent: | 4.65 |
| Report Date: | 2017-03-31 |
| Date: | 2017-03-31 |
| Currency: | EUR |
| Eps Actual: | 1.42 |
| Eps Estimate: | 1.27 |
| Eps Difference: | 0.15 |
| Surprise Percent: | 11.81 |
| Report Date: | 2015-09-30 |
| Date: | 2015-09-30 |
| Currency: | EUR |
| Eps Actual: | 1.24 |
| Report Date: | 2015-06-30 |
| Date: | 2015-06-30 |
| Currency: | EUR |
| Eps Actual: | 0.99 |
| Date: | 2022-12-31 |
| Period: | +1y |
| Growth: | 0.11 |
| Earnings Estimate Avg: | 7.06 |
| Earnings Estimate Low: | 6.57 |
| Earnings Estimate High: | 7.77 |
| Earnings Estimate Year Ago Eps: | 6.33 |
| Earnings Estimate Number Of Analysts: | 17.00 |
| Earnings Estimate Growth: | 0.11 |
| Revenue Estimate Avg: | 39471100000.00 |
| Revenue Estimate Low: | 38094000000.00 |
| Revenue Estimate High: | 41036000000.00 |
| Revenue Estimate Number Of Analysts: | 19.00 |
| Revenue Estimate Growth: | 0.04 |
| Eps Trend Current: | 7.06 |
| Eps Trend7days Ago: | 7.52 |
| Eps Trend30days Ago: | 7.52 |
| Eps Trend60days Ago: | 7.52 |
| Eps Trend90days Ago: | 7.52 |
| Eps Revisions Down Last7days: | 1.00 |
| Eps Revisions Down Last30days: | 1.00 |
| Date: | 2021-12-31 |
| Earnings Estimate Avg: | 6.33 |
| Earnings Estimate Low: | 6.05 |
| Earnings Estimate High: | 6.99 |
| Earnings Estimate Number Of Analysts: | 17.00 |
| Revenue Estimate Avg: | 37616300000.00 |
| Revenue Estimate Low: | 36790000000.00 |
| Revenue Estimate High: | 39118000000.00 |
| Revenue Estimate Number Of Analysts: | 19.00 |
| Eps Trend Current: | 6.33 |
| Eps Trend7days Ago: | 6.88 |
| Eps Trend30days Ago: | 6.88 |
| Eps Trend60days Ago: | 6.88 |
| Eps Trend90days Ago: | 6.88 |
| Eps Revisions Up Last7days: | 1.00 |
| Eps Revisions Up Last30days: | 2.00 |
| Date: | 2021-09-30 |
| Earnings Estimate Avg: | 1.96 |
| Earnings Estimate Low: | 1.92 |
| Earnings Estimate High: | 2.02 |
| Earnings Estimate Number Of Analysts: | 4.00 |
| Revenue Estimate Avg: | 10016500000.00 |
| Revenue Estimate Low: | 9898000000.00 |
| Revenue Estimate High: | 10109900000.00 |
| Revenue Estimate Number Of Analysts: | 4.00 |
| Eps Trend Current: | 1.96 |
| Date: | 2019-12-31 |
| Period: | +1y |
| Growth: | 0.05 |
| Earnings Estimate Year Ago Eps: | 5.46 |
| Earnings Estimate Growth: | 0.05 |
| Revenue Estimate Avg: | 35981200000.00 |
| Revenue Estimate Low: | 35059000000.00 |
| Revenue Estimate High: | 37315000000.00 |
| Revenue Estimate Number Of Analysts: | 13.00 |
| Revenue Estimate Growth: | 0.03 |
| Eps Trend7days Ago: | 5.76 |
| Eps Trend30days Ago: | 5.76 |
| Eps Trend60days Ago: | 5.76 |
| Eps Trend90days Ago: | 5.76 |
| Eps Revisions Up Last30days: | 2.00 |
| Date: | 2019-03-31 |
| Period: | +1q |
| Growth: | 0.10 |
| Earnings Estimate Year Ago Eps: | 1.28 |
| Earnings Estimate Growth: | 0.10 |
| Revenue Estimate Avg: | 8261410000.00 |
| Revenue Estimate Low: | 8088820000.00 |
| Revenue Estimate High: | 8434000000.00 |
| Revenue Estimate Number Of Analysts: | 2.00 |
| Revenue Estimate Growth: | 0.04 |
| Eps Trend7days Ago: | 1.42 |
| Eps Trend30days Ago: | 1.42 |
| Eps Trend60days Ago: | 1.42 |
| Eps Trend90days Ago: | 1.42 |
| Date: | 2018-12-31 |
| Growth: | -0.01 |
| Earnings Estimate Year Ago Eps: | 5.54 |
| Earnings Estimate Growth: | -0.01 |
| Revenue Estimate Avg: | 34892000000.00 |
| Revenue Estimate Low: | 33943000000.00 |
| Revenue Estimate High: | 35656000000.00 |
| Revenue Estimate Number Of Analysts: | 13.00 |
| Revenue Estimate Growth: | -0.00 |
| Eps Trend7days Ago: | 5.46 |
| Eps Trend30days Ago: | 5.46 |
| Eps Trend60days Ago: | 5.46 |
| Eps Trend90days Ago: | 5.46 |
| Eps Revisions Up Last30days: | 1.00 |
| Date: | 2018-09-30 |
| Growth: | 0.01 |
| Earnings Estimate Avg: | 1.73 |
| Earnings Estimate Low: | 1.68 |
| Earnings Estimate High: | 1.78 |
| Earnings Estimate Year Ago Eps: | 1.71 |
| Earnings Estimate Number Of Analysts: | 5.00 |
| Earnings Estimate Growth: | 0.01 |
| Revenue Estimate Avg: | 9279300000.00 |
| Revenue Estimate Low: | 8966000000.00 |
| Revenue Estimate High: | 9816510000.00 |
| Revenue Estimate Number Of Analysts: | 5.00 |
| Revenue Estimate Growth: | 0.02 |
| Eps Trend Current: | 1.73 |
| Eps Trend7days Ago: | 1.73 |
| Eps Trend30days Ago: | 1.67 |
| Eps Trend60days Ago: | 1.65 |
| Eps Trend90days Ago: | 1.65 |
| Eps Revisions Up Last30days: | 1.00 |
| Eps Revisions Down Last7days: | 1.00 |
| Date: | 2018-06-30 |
| Growth: | -0.08 |
| Earnings Estimate Avg: | 1.23 |
| Earnings Estimate Low: | 1.20 |
| Earnings Estimate High: | 1.27 |
| Earnings Estimate Year Ago Eps: | 1.35 |
| Earnings Estimate Number Of Analysts: | 5.00 |
| Earnings Estimate Growth: | -0.08 |
| Revenue Estimate Avg: | 8315370000.00 |
| Revenue Estimate Low: | 8242000000.00 |
| Revenue Estimate High: | 8475870000.00 |
| Revenue Estimate Number Of Analysts: | 5.00 |
| Revenue Estimate Growth: | -0.04 |
| Eps Trend Current: | 1.23 |
| Eps Trend7days Ago: | 1.23 |
| Eps Trend30days Ago: | 1.15 |
| Eps Trend60days Ago: | 1.16 |
| Eps Trend90days Ago: | 1.17 |
| Eps Revisions Up Last7days: | 1.00 |
| Eps Revisions Up Last30days: | 2.00 |
| Date: | 2018-03-31 |
| Growth: | -0.20 |
| Earnings Estimate Avg: | 1.13 |
| Earnings Estimate Low: | 1.04 |
| Earnings Estimate High: | 1.25 |
| Earnings Estimate Year Ago Eps: | 1.42 |
| Earnings Estimate Number Of Analysts: | 3.00 |
| Earnings Estimate Growth: | -0.20 |
| Revenue Estimate Avg: | 7983720000.00 |
| Revenue Estimate Low: | 7699000000.00 |
| Revenue Estimate High: | 8214000000.00 |
| Revenue Estimate Number Of Analysts: | 3.00 |
| Revenue Estimate Growth: | -0.07 |
| Eps Trend Current: | 1.13 |
| Eps Trend7days Ago: | 1.13 |
| Eps Trend30days Ago: | 1.17 |
| Eps Trend60days Ago: | 1.31 |
| Eps Trend90days Ago: | 1.25 |
| Date: | 2024-09-30 |
| Eps Actual: | 15.0 |
| Date: | 2017-12-31 |
| Eps Actual: | 7.78 |